Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by JABombardieron Feb 25, 2009 6:22pm
363 Views
Post# 15803626

3.84M options & 126M shares="DILLUTIION..back $0.0

3.84M options & 126M shares="DILLUTIION..back $0.0

Shares Issued 126,862,497
Close 2009-02-24 C$ 0.085
 now add 3.84M options=Dillution....!!!

Stem Cell Therapeutics grants 10-cent options

2009-02-25 09:37 EST - Options Proposed

Dr. Alan Moore reports

STEM CELL THERAPEUTICS CORP. ANNOUNCES ISSUANCE OF STOCK OPTIONS

Stem Cell Therapeutics Corp. has issued stock options to officers and directors of the company. These options were issued in connection with a reduction of executive salaries and board of directors' fees, all effective as of Jan. 1, 2009.

Stem Cell has issued a total of 3.84 million stock options to the company's officers and board of directors at an exercise price of 10 cents per share. These options will expire no later than Feb. 25, 2014, subject to applicable vesting provisions. These options were awarded in accordance with the company's stock option plan.

The remainder is available to Stockwatch subscribers.

NICE PUMP...Guys....LOL

Bullboard Posts